Riskpilot← Back to searchSign inGet full accessSofrosyne AB
ABActiveOrg 5567913925Molngatan 7Other social work activities without accommodation n.e.c. · NACE 8899Est. 20091 employees
Revenue 2025
SEK 664K
+86% vs 2024
EBITDA margin
62.3%
+302% vs 2024
Equity ratio
93.4%
Financial strength
Net profit 2025
SEK 329K
+21% vs 2024
| Revenue | SEK 664K | +86% |
| EBITDA | SEK 414K | +302% |
| Net profit | SEK 329K | +21% |
| Total assets | SEK 2,4M | -2% |
| Equity | SEK 2,2M | -7% |
| Employees | 1 | — |
Legal name
Sofrosyne AB
Org number
5567913925
Legal form
Aktiebolag
NACE code
8899 · Other social work activities without accommodation n.e.c.
Founded
20 oktober 2009
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva entreprenadverksamhet inom vård och behandling samt därmed förenlig verksamhet. Förvaltning av och handel med värdepapper, för en begränsad och sluten krets av ägare. Utveckling och tillhandahållande av digitala produkter, verksamhetsrevision, utbildning, projektledning, kvalitetsledning samt konsultverksamhet inom vård- och omsorg. Bolaget bedriver också bokförlag, webbtidning samt försäljning av litteratur samt vårdrelaterade produkter.
Address
Molngatan 7
Phone
+46708717900
Email
erland.olsson@sofrosyne.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 3 830 | 2 881 | 2 819 | 2 127 | 700 | 764 | 357 | 664 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 63 | 311 | 398 | −271 | 897 | 428 | 604 | 244 | 424 | 103 | 414 |
| Depreciation & amort. | −44 | −85 | −129 | −83 | −83 | −83 | −41 | −92 | −130 | −65 | −0 |
| EBIT | 19 | 226 | 269 | −354 | 814 | 345 | 563 | 152 | 294 | 38 | 414 |
| Net financials | 1 | — | −15 | −11 | −8 | −1 | — | 3 384 | 65 | 10 | 1 |
| Profit before tax | 17 | 185 | 180 | 17 | 621 | 343 | 563 | 3 537 | 269 | 348 | 414 |
| Tax | −9 | −48 | −48 | −7 | −137 | −80 | −119 | −33 | −56 | −75 | −85 |
| Net profit | 8 | 137 | 132 | 10 | 484 | 263 | 444 | 3 504 | 213 | 273 | 329 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 602 | 2 121 | 2 546 | 1 694 | 1 426 | 1 729 | 1 863 | 3 834 | 2 993 | 2 427 | 2 375 |
| Equity | 729 | 866 | 998 | 1 008 | 743 | 1 006 | 1 450 | 3 604 | 2 616 | 2 390 | 2 219 |
| Long-term debt | 0 | 139 | 234 | 180 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 581 | 784 | 908 | 481 | 473 | 513 | 202 | 21 | 76 | 37 | 156 |
| Total debt | 581 | 923 | 1 142 | 661 | 473 | 513 | 202 | 21 | 76 | 37 | 156 |
EBITDA margin
62.3%
This company
15.8%
Market median
+294% vs market
20152025
Equity ratio
93.4%
This company
38.2%
Market median
+145% vs market
20152025
Return on equity
14.8%
This company
18.4%
Market median
+20% vs market
20152025
Net profit margin
49.5%
This company
8.1%
Market median
+511% vs market
20152025
Asset turnover
0.28×
This company
1.12×
Market median
-75% vs market
20152025
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20152025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CV Chief Auditor | Chief Auditor | 2021 | — | — |
ME Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
KE External Signatory | External Signatory | 2020 | — | — |
LL Chief Auditor | Chief Auditor | 2020 | — | — |
ÅM Audit | Audit | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Deputy Board Member | 2025 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Sofrosyne AB 
Vårdexperten Sverige ABBoard members of Sofrosyne AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carin Viola Christina Forsström | Chief Auditor | 0 companies |
| Mauritz Erland Stintzing Olsson | Chief Executive Officer | 0 companies |
| Kerstin Elisabeth Asplund | External Signatory | 0 companies |
| Lars Ludwig Holmgren | Chief Auditor | 0 companies |
| Åsa Maria Jeanson | Audit | 0 companies |
| Ellenor Josefine Larsson | Board of Directors | 0 companies |
| Björn Erland Hammarling | Deputy Board Member | 0 companies |
| Kerstin Elisabeth Asplund | Deputy Board Member | 0 companies |